Vittorio Fusco

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Topics

Bone Mineral Density

Squamous Cell Carcinoma

Affordable Care Act

Top Venues

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Acta clinica Belgica

This page only lists publications with an associated author ORCID identifier.

Publications

Rodolfo Mauceri, Rita Coniglio, Antonia Abbinante, Paola Carcieri, Domenico Tomassi, Vera Panzarella, Olga Di Fede, Francesco Bertoldo, Vittorio Fusco, Alberto Bedogni, Giuseppina Campisi
The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (8) (2022)
Vittorio Fusco, Giuseppina Campisi, Alberto Bedogni
One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (9) (2022)
Vittorio Fusco, Maura Rossi, Antonella Fasciolo, Alessio Gambino, Serena Palmeri
Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical points. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (12) (2022)
Vittorio Fusco, Maura Rossi, Iolanda De Martino, Manuela Alessio, Antonella Fasciolo, Gianmauro Numico
Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions. Acta clinica Belgica 73 (2) (2017)
Vittorio Fusco, Alberto Bedogni, Alfredo Addeo, Giuseppina Campisi
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 25 (2) (2016)